A University of Michigan team developed new technology to separate aggressive stage 0 breast cancer from nonaggressive forms, eventually aiming to guide treatment paths.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Comprehensive Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined the University of Michigan Health System in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
In inflammatory breast cancer cells, the gene RhoC controls cell metabolism and regulates energy — a ‘vulnerability’ future treatments could exploit.
Researchers examined the DNA of lymphomas that occur in and around the eye, and found several mutations for which targeted therapies are being tested in other cancer types.
An investigation from the University of Michigan could eventually lead to new therapies that take aim at the most aggressive type of breast cancer.
New research explains why this difficult-to-treat disease becomes resistant to chemotherapy, suggesting potential future treatment options.
A new survey, published in JAMA, finds that sexual harassment and gender bias among physicians continues.